Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug–drug interaction profiles

Pu ShiDrug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co, 35 Landsdowne Street, Cambridge, MA, USA, Correspondence[email protected]

Mingxiang LiaoDrug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co, 35 Landsdowne Street, Cambridge, MA, USA,

Bei-Ching ChuangDrug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co, 35 Landsdowne Street, Cambridge, MA, USA,

Robert GriffinDrug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co, 35 Landsdowne Street, Cambridge, MA, USA,

Judy ShiCancer Pharmacology, Takeda Pharmaceuticals International Co, 40 Landsdowne Street, Cambridge, MA, USA, and

Marc HyerCancer Pharmacology, Takeda Pharmaceuticals International Co, 40 Landsdowne Street, Cambridge, MA, USA, and

John K. FallonDivision of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Philip C. SmithDivision of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Chao LiDrug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co, 35 Landsdowne Street, Cambridge, MA, USA,

Cindy Q. XiaDrug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co, 35 Landsdowne Street, Cambridge, MA, USA,

show all

Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug–drug interaction profiles

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug–drug interaction profiles

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date